Global and United States DNA Repair Drugs Market Report & Forecast 2023-2028

Report ID: 1844141 | Published Date: Oct 2024 | No. of Page: 118 | Base Year: 2023 | Rating: 4.3 | Webstory: Check our Web story
1 Study Coverage
    1.1 DNA Repair Drugs Product Introduction
    1.2 Global DNA Repair Drugs Outlook 2017 VS 2022 VS 2028
        1.2.1 Global DNA Repair Drugs Sales in US$ Million for the Year 2017-2028
        1.2.2 Global DNA Repair Drugs Sales in Volume for the Year 2017-2028
    1.3 United States DNA Repair Drugs Outlook 2017 VS 2022 VS 2028
        1.3.1 United States DNA Repair Drugs Sales in US$ Million for the Year 2017-2028
        1.3.2 United States DNA Repair Drugs Sales in Volume for the Year 2017-2028
    1.4 DNA Repair Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States DNA Repair Drugs in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of DNA Repair Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 DNA Repair Drugs Market Dynamics
        1.5.1 DNA Repair Drugs Industry Trends
        1.5.2 DNA Repair Drugs Market Drivers
        1.5.3 DNA Repair Drugs Market Challenges
        1.5.4 DNA Repair Drugs Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 DNA Repair Drugs Market Segment by Type
        2.1.1 PARP Inhibitors
        2.1.2 Other
    2.2 Global DNA Repair Drugs Market Size by Type
        2.2.1 Global DNA Repair Drugs Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global DNA Repair Drugs Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global DNA Repair Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States DNA Repair Drugs Market Size by Type
        2.3.1 United States DNA Repair Drugs Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States DNA Repair Drugs Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States DNA Repair Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 DNA Repair Drugs Market Segment by Application
        3.1.1 Oncological
        3.1.2 Stroke
    3.2 Global DNA Repair Drugs Market Size by Application
        3.2.1 Global DNA Repair Drugs Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global DNA Repair Drugs Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global DNA Repair Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States DNA Repair Drugs Market Size by Application
        3.3.1 United States DNA Repair Drugs Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States DNA Repair Drugs Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States DNA Repair Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global DNA Repair Drugs Competitor Landscape by Company
    4.1 Global DNA Repair Drugs Market Size by Company
        4.1.1 Top Global DNA Repair Drugs Manufacturers Ranked by Revenue (2021)
        4.1.2 Global DNA Repair Drugs Revenue by Manufacturer (2017-2022)
        4.1.3 Global DNA Repair Drugs Sales by Manufacturer (2017-2022)
        4.1.4 Global DNA Repair Drugs Price by Manufacturer (2017-2022)
    4.2 Global DNA Repair Drugs Concentration Ratio (CR)
        4.2.1 DNA Repair Drugs Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of DNA Repair Drugs in 2021
        4.2.3 Global DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global DNA Repair Drugs Manufacturing Base Distribution, Product Type
        4.3.1 Global DNA Repair Drugs Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers DNA Repair Drugs Product Type
        4.3.3 Date of International Manufacturers Enter into DNA Repair Drugs Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States DNA Repair Drugs Market Size by Company
        4.5.1 Top DNA Repair Drugs Players in United States, Ranked by Revenue (2021)
        4.5.2 United States DNA Repair Drugs Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States DNA Repair Drugs Sales by Players (2020, 2021 & 2022)
5 Global DNA Repair Drugs Market Size by Region
    5.1 Global DNA Repair Drugs Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global DNA Repair Drugs Market Size in Volume by Region (2017-2028)
        5.2.1 Global DNA Repair Drugs Sales in Volume by Region: 2017-2022
        5.2.2 Global DNA Repair Drugs Sales in Volume Forecast by Region (2023-2028)
    5.3 Global DNA Repair Drugs Market Size in Value by Region (2017-2028)
        5.3.1 Global DNA Repair Drugs Sales in Value by Region: 2017-2022
        5.3.2 Global DNA Repair Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America DNA Repair Drugs Market Size YoY Growth 2017-2028
        6.1.2 North America DNA Repair Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific DNA Repair Drugs Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific DNA Repair Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe DNA Repair Drugs Market Size YoY Growth 2017-2028
        6.3.2 Europe DNA Repair Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America DNA Repair Drugs Market Size YoY Growth 2017-2028
        6.4.2 Latin America DNA Repair Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa DNA Repair Drugs Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa DNA Repair Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 4SC AG
        7.1.1 4SC AG Corporation Information
        7.1.2 4SC AG Description and Business Overview
        7.1.3 4SC AG DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 4SC AG DNA Repair Drugs Products Offered
        7.1.5 4SC AG Recent Development
    7.2 ARCAGY/ GINECO GROUP
        7.2.1 ARCAGY/ GINECO GROUP Corporation Information
        7.2.2 ARCAGY/ GINECO GROUP Description and Business Overview
        7.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 ARCAGY/ GINECO GROUP DNA Repair Drugs Products Offered
        7.2.5 ARCAGY/ GINECO GROUP Recent Development
    7.3 Bristol Myers Squibb
        7.3.1 Bristol Myers Squibb Corporation Information
        7.3.2 Bristol Myers Squibb Description and Business Overview
        7.3.3 Bristol Myers Squibb DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Bristol Myers Squibb DNA Repair Drugs Products Offered
        7.3.5 Bristol Myers Squibb Recent Development
    7.4 British Columbia Cancer Agency
        7.4.1 British Columbia Cancer Agency Corporation Information
        7.4.2 British Columbia Cancer Agency Description and Business Overview
        7.4.3 British Columbia Cancer Agency DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 British Columbia Cancer Agency DNA Repair Drugs Products Offered
        7.4.5 British Columbia Cancer Agency Recent Development
    7.5 Cambridge University Hospitals NHS Foundation Trust
        7.5.1 Cambridge University Hospitals NHS Foundation Trust Corporation Information
        7.5.2 Cambridge University Hospitals NHS Foundation Trust Description and Business Overview
        7.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Products Offered
        7.5.5 Cambridge University Hospitals NHS Foundation Trust Recent Development
    7.6 Genentech
        7.6.1 Genentech Corporation Information
        7.6.2 Genentech Description and Business Overview
        7.6.3 Genentech DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Genentech DNA Repair Drugs Products Offered
        7.6.5 Genentech Recent Development
    7.7 Georgetown University
        7.7.1 Georgetown University Corporation Information
        7.7.2 Georgetown University Description and Business Overview
        7.7.3 Georgetown University DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Georgetown University DNA Repair Drugs Products Offered
        7.7.5 Georgetown University Recent Development
    7.8 German Breast Group
        7.8.1 German Breast Group Corporation Information
        7.8.2 German Breast Group Description and Business Overview
        7.8.3 German Breast Group DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 German Breast Group DNA Repair Drugs Products Offered
        7.8.5 German Breast Group Recent Development
    7.9 GlaxoSmithKline
        7.9.1 GlaxoSmithKline Corporation Information
        7.9.2 GlaxoSmithKline Description and Business Overview
        7.9.3 GlaxoSmithKline DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 GlaxoSmithKline DNA Repair Drugs Products Offered
        7.9.5 GlaxoSmithKline Recent Development
    7.10 Jiangsu Hengrui Medicine
        7.10.1 Jiangsu Hengrui Medicine Corporation Information
        7.10.2 Jiangsu Hengrui Medicine Description and Business Overview
        7.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Jiangsu Hengrui Medicine DNA Repair Drugs Products Offered
        7.10.5 Jiangsu Hengrui Medicine Recent Development
    7.11 Johnson & Johnson
        7.11.1 Johnson & Johnson Corporation Information
        7.11.2 Johnson & Johnson Description and Business Overview
        7.11.3 Johnson & Johnson DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.11.4 Johnson & Johnson DNA Repair Drugs Products Offered
        7.11.5 Johnson & Johnson Recent Development
    7.12 Jonsson Comprehensive Cancer Center
        7.12.1 Jonsson Comprehensive Cancer Center Corporation Information
        7.12.2 Jonsson Comprehensive Cancer Center Description and Business Overview
        7.12.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.12.4 Jonsson Comprehensive Cancer Center Products Offered
        7.12.5 Jonsson Comprehensive Cancer Center Recent Development
    7.13 Karyopharm Therapeutics
        7.13.1 Karyopharm Therapeutics Corporation Information
        7.13.2 Karyopharm Therapeutics Description and Business Overview
        7.13.3 Karyopharm Therapeutics DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.13.4 Karyopharm Therapeutics Products Offered
        7.13.5 Karyopharm Therapeutics Recent Development
    7.14 KuDOS Pharmaceuticals
        7.14.1 KuDOS Pharmaceuticals Corporation Information
        7.14.2 KuDOS Pharmaceuticals Description and Business Overview
        7.14.3 KuDOS Pharmaceuticals DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.14.4 KuDOS Pharmaceuticals Products Offered
        7.14.5 KuDOS Pharmaceuticals Recent Development
    7.15 National Health Service
        7.15.1 National Health Service Corporation Information
        7.15.2 National Health Service Description and Business Overview
        7.15.3 National Health Service DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.15.4 National Health Service Products Offered
        7.15.5 National Health Service Recent Development
    7.16 National Institutes of Health
        7.16.1 National Institutes of Health Corporation Information
        7.16.2 National Institutes of Health Description and Business Overview
        7.16.3 National Institutes of Health DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.16.4 National Institutes of Health Products Offered
        7.16.5 National Institutes of Health Recent Development
    7.17 Tesaro
        7.17.1 Tesaro Corporation Information
        7.17.2 Tesaro Description and Business Overview
        7.17.3 Tesaro DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.17.4 Tesaro Products Offered
        7.17.5 Tesaro Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 DNA Repair Drugs Industry Chain Analysis
    8.2 DNA Repair Drugs Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 DNA Repair Drugs Distributors
    8.3 DNA Repair Drugs Production Mode & Process
    8.4 DNA Repair Drugs Sales and Marketing
        8.4.1 DNA Repair Drugs Sales Channels
        8.4.2 DNA Repair Drugs Distributors
    8.5 DNA Repair Drugs Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer
List of Tables
    Table 1. DNA Repair Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. DNA Repair Drugs Market Trends
    Table 3. DNA Repair Drugs Market Drivers
    Table 4. DNA Repair Drugs Market Challenges
    Table 5. DNA Repair Drugs Market Restraints
    Table 6. Global DNA Repair Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States DNA Repair Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global DNA Repair Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States DNA Repair Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top DNA Repair Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global DNA Repair Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global DNA Repair Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global DNA Repair Drugs Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global DNA Repair Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global DNA Repair Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global DNA Repair Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global DNA Repair Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Repair Drugs as of 2021)
    Table 18. Top Players of DNA Repair Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers DNA Repair Drugs Product Type
    Table 20. Date of International Manufacturers Enter into DNA Repair Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top DNA Repair Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States DNA Repair Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States DNA Repair Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States DNA Repair Drugs Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States DNA Repair Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global DNA Repair Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global DNA Repair Drugs Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global DNA Repair Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global DNA Repair Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global DNA Repair Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America DNA Repair Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America DNA Repair Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific DNA Repair Drugs Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific DNA Repair Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe DNA Repair Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe DNA Repair Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America DNA Repair Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa DNA Repair Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa DNA Repair Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa DNA Repair Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. 4SC AG Corporation Information
    Table 43. 4SC AG Description and Business Overview
    Table 44. 4SC AG DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. 4SC AG DNA Repair Drugs Product
    Table 46. 4SC AG Recent Development
    Table 47. ARCAGY/ GINECO GROUP Corporation Information
    Table 48. ARCAGY/ GINECO GROUP Description and Business Overview
    Table 49. ARCAGY/ GINECO GROUP DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. ARCAGY/ GINECO GROUP Product
    Table 51. ARCAGY/ GINECO GROUP Recent Development
    Table 52. Bristol Myers Squibb Corporation Information
    Table 53. Bristol Myers Squibb Description and Business Overview
    Table 54. Bristol Myers Squibb DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Bristol Myers Squibb Product
    Table 56. Bristol Myers Squibb Recent Development
    Table 57. British Columbia Cancer Agency Corporation Information
    Table 58. British Columbia Cancer Agency Description and Business Overview
    Table 59. British Columbia Cancer Agency DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. British Columbia Cancer Agency Product
    Table 61. British Columbia Cancer Agency Recent Development
    Table 62. Cambridge University Hospitals NHS Foundation Trust Corporation Information
    Table 63. Cambridge University Hospitals NHS Foundation Trust Description and Business Overview
    Table 64. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Cambridge University Hospitals NHS Foundation Trust Product
    Table 66. Cambridge University Hospitals NHS Foundation Trust Recent Development
    Table 67. Genentech Corporation Information
    Table 68. Genentech Description and Business Overview
    Table 69. Genentech DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Genentech Product
    Table 71. Genentech Recent Development
    Table 72. Georgetown University Corporation Information
    Table 73. Georgetown University Description and Business Overview
    Table 74. Georgetown University DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Georgetown University Product
    Table 76. Georgetown University Recent Development
    Table 77. German Breast Group Corporation Information
    Table 78. German Breast Group Description and Business Overview
    Table 79. German Breast Group DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. German Breast Group Product
    Table 81. German Breast Group Recent Development
    Table 82. GlaxoSmithKline Corporation Information
    Table 83. GlaxoSmithKline Description and Business Overview
    Table 84. GlaxoSmithKline DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. GlaxoSmithKline Product
    Table 86. GlaxoSmithKline Recent Development
    Table 87. Jiangsu Hengrui Medicine Corporation Information
    Table 88. Jiangsu Hengrui Medicine Description and Business Overview
    Table 89. Jiangsu Hengrui Medicine DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Jiangsu Hengrui Medicine Product
    Table 91. Jiangsu Hengrui Medicine Recent Development
    Table 92. Johnson & Johnson Corporation Information
    Table 93. Johnson & Johnson Description and Business Overview
    Table 94. Johnson & Johnson DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. Johnson & Johnson Product
    Table 96. Johnson & Johnson Recent Development
    Table 97. Jonsson Comprehensive Cancer Center Corporation Information
    Table 98. Jonsson Comprehensive Cancer Center Description and Business Overview
    Table 99. Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 100. Jonsson Comprehensive Cancer Center Product
    Table 101. Jonsson Comprehensive Cancer Center Recent Development
    Table 102. Karyopharm Therapeutics Corporation Information
    Table 103. Karyopharm Therapeutics Description and Business Overview
    Table 104. Karyopharm Therapeutics DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 105. Karyopharm Therapeutics Product
    Table 106. Karyopharm Therapeutics Recent Development
    Table 107. KuDOS Pharmaceuticals Corporation Information
    Table 108. KuDOS Pharmaceuticals Description and Business Overview
    Table 109. KuDOS Pharmaceuticals DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. KuDOS Pharmaceuticals Product
    Table 111. KuDOS Pharmaceuticals Recent Development
    Table 112. National Health Service Corporation Information
    Table 113. National Health Service Description and Business Overview
    Table 114. National Health Service DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. National Health Service Product
    Table 116. National Health Service Recent Development
    Table 117. National Institutes of Health Corporation Information
    Table 118. National Institutes of Health Description and Business Overview
    Table 119. National Institutes of Health DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. National Institutes of Health Product
    Table 121. National Institutes of Health Recent Development
    Table 122. Tesaro Corporation Information
    Table 123. Tesaro Description and Business Overview
    Table 124. Tesaro DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 125. Tesaro Product
    Table 126. Tesaro Recent Development
    Table 127. Key Raw Materials Lists
    Table 128. Raw Materials Key Suppliers Lists
    Table 129. DNA Repair Drugs Customers List
    Table 130. DNA Repair Drugs Distributors List
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. DNA Repair Drugs Product Picture
    Figure 2. Global DNA Repair Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global DNA Repair Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global DNA Repair Drugs Sales 2017-2028 (K Units)
    Figure 5. United States DNA Repair Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States DNA Repair Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States DNA Repair Drugs Sales 2017-2028 (K Units)
    Figure 8. United States DNA Repair Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States DNA Repair Drugs Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. DNA Repair Drugs Report Years Considered
    Figure 11. Product Picture of PARP Inhibitors
    Figure 12. Product Picture of Other
    Figure 13. Global DNA Repair Drugs Market Share by Type in 2022 & 2028
    Figure 14. Global DNA Repair Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global DNA Repair Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global DNA Repair Drugs Sales by Type (2017-2028) & (K Units)
    Figure 17. Global DNA Repair Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global DNA Repair Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 19. United States DNA Repair Drugs Market Share by Type in 2022 & 2028
    Figure 20. United States DNA Repair Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States DNA Repair Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States DNA Repair Drugs Sales by Type (2017-2028) & (K Units)
    Figure 23. United States DNA Repair Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States DNA Repair Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 25. Product Picture of Oncological
    Figure 26. Product Picture of Stroke
    Figure 27. Global DNA Repair Drugs Market Share by Application in 2022 & 2028
    Figure 28. Global DNA Repair Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 29. Global DNA Repair Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 30. Global DNA Repair Drugs Sales by Application (2017-2028) & (K Units)
    Figure 31. Global DNA Repair Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 32. Global DNA Repair Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 33. United States DNA Repair Drugs Market Share by Application in 2022 & 2028
    Figure 34. United States DNA Repair Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. United States DNA Repair Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 36. United States DNA Repair Drugs Sales by Application (2017-2028) & (K Units)
    Figure 37. United States DNA Repair Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 38. United States DNA Repair Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 39. North America DNA Repair Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 40. North America DNA Repair Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 41. U.S. DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Canada DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Europe DNA Repair Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 44. Europe DNA Repair Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. Germany DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. France DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. U.K. DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Italy DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Russia DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Asia-Pacific DNA Repair Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 51. Asia-Pacific DNA Repair Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. China DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Japan DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. South Korea DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. India DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Australia DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Taiwan DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Indonesia DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Thailand DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Malaysia DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Philippines DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Latin America DNA Repair Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 63. Latin America DNA Repair Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 64. Mexico DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Brazil DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Argentina DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa DNA Repair Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 68. Middle East & Africa DNA Repair Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Saudi Arabia DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. U.A.E DNA Repair Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. DNA Repair Drugs Value Chain
    Figure 73. DNA Repair Drugs Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
4SC AG
ARCAGY/ GINECO GROUP
Bristol Myers Squibb
British Columbia Cancer Agency
Cambridge University Hospitals NHS Foundation Trust
Genentech
Georgetown University
German Breast Group
GlaxoSmithKline
Jiangsu Hengrui Medicine
Johnson & Johnson
Jonsson Comprehensive Cancer Center
Karyopharm Therapeutics
KuDOS Pharmaceuticals
National Health Service
National Institutes of Health
Tesaro
Frequently Asked Questions
DNA Repair Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
DNA Repair Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
DNA Repair Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Ophthalmic Devices

Ophthalmic Devices market is segmented by region (country), players, by Type and by Application.  ... Read More